Diagnostic and Interventional Cardiology published interesting, thought-provoking article on the inclusion of economic costs into product evaluations—presently the FDA approval process precludes such criteria. The…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.